These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 20644117

  • 1. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets.
    Hislop AD, Palendira U, Leese AM, Arkwright PD, Rohrlich PS, Tangye SG, Gaspar HB, Lankester AC, Moretta A, Rickinson AB.
    Blood; 2010 Oct 28; 116(17):3249-57. PubMed ID: 20644117
    [Abstract] [Full Text] [Related]

  • 2. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
    Palendira U, Low C, Chan A, Hislop AD, Ho E, Phan TG, Deenick E, Cook MC, Riminton DS, Choo S, Loh R, Alvaro F, Booth C, Gaspar HB, Moretta A, Khanna R, Rickinson AB, Tangye SG.
    PLoS Biol; 2011 Nov 28; 9(11):e1001187. PubMed ID: 22069374
    [Abstract] [Full Text] [Related]

  • 3. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease.
    Sharifi R, Sinclair JC, Gilmour KC, Arkwright PD, Kinnon C, Thrasher AJ, Gaspar HB.
    Blood; 2004 May 15; 103(10):3821-7. PubMed ID: 14726378
    [Abstract] [Full Text] [Related]

  • 4. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
    Dupré L, Andolfi G, Tangye SG, Clementi R, Locatelli F, Aricò M, Aiuti A, Roncarolo MG.
    Blood; 2005 Jun 01; 105(11):4383-9. PubMed ID: 15677558
    [Abstract] [Full Text] [Related]

  • 5. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R, Ochs HD, Wolf H, Bonnefoy JY, Biassoni R, Moretta L, Notarangelo LD, Moretta A.
    J Exp Med; 2000 Aug 07; 192(3):337-46. PubMed ID: 10934222
    [Abstract] [Full Text] [Related]

  • 6. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
    Malbrán A, Belmonte L, Ruibal-Ares B, Baré P, Bracco MM.
    Medicina (B Aires); 2003 Aug 07; 63(1):70-6. PubMed ID: 12673966
    [Abstract] [Full Text] [Related]

  • 7. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.
    Tangye SG.
    J Clin Immunol; 2014 Oct 07; 34(7):772-9. PubMed ID: 25085526
    [Abstract] [Full Text] [Related]

  • 8. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.
    Nagy N, Mattsson K, Maeda A, Liu A, Székely L, Klein E.
    Immunol Lett; 2002 Jun 03; 82(1-2):141-7. PubMed ID: 12008045
    [Abstract] [Full Text] [Related]

  • 9. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
    Sayós J, Nguyen KB, Wu C, Stepp SE, Howie D, Schatzle JD, Kumar V, Biron CA, Terhorst C.
    Int Immunol; 2000 Dec 03; 12(12):1749-57. PubMed ID: 11099315
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus.
    Howie D, Sayos J, Terhorst C, Morra M.
    Curr Opin Immunol; 2000 Aug 03; 12(4):474-8. PubMed ID: 10899030
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. X-linked lymphoproliferative disease: a progressive immunodeficiency.
    Morra M, Howie D, Grande MS, Sayos J, Wang N, Wu C, Engel P, Terhorst C.
    Annu Rev Immunol; 2001 Aug 03; 19():657-82. PubMed ID: 11244050
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.